ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | | | | | |
| | Tissue enhanced | 0 |
CASS4 | Cas scaffolding protein family member 4 | | | | |
|
| | Tissue enhanced | 0 |
CCL17 | Chemokine (C-C motif) ligand 17 | | | | |
|
| | Tissue enhanced | 0 |
CCL19 | Chemokine (C-C motif) ligand 19 | | | | | |
| | Tissue enhanced | 0 |
CCL22 | Chemokine (C-C motif) ligand 22 | | | | | |
| | Tissue enhanced | 0 |
CCR2 | Chemokine (C-C motif) receptor 2 | | | | |
|
| | Tissue enhanced | 0 |
CCR4 | Chemokine (C-C motif) receptor 4 | | | | |
|
| | Tissue enhanced | 0 |
CD300E | CD300e molecule | | | | |
|
| | Tissue enhanced | 0 |
CD300LB | CD300 molecule-like family member b | | | | | |
| | Tissue enhanced | 0 |
CEACAM3 | Carcinoembryonic antigen-related cell adhesion molecule 3 | | | | |
|
| | Tissue enhanced | 0 |
CHI3L2 | Chitinase 3-like 2 | | | | |
|
| | Tissue enhanced | 0 |
CLEC4A | C-type lectin domain family 4, member A | | | | |
|
| | Tissue enhanced | 0 |
CLEC4E | C-type lectin domain family 4, member E | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
CLEC6A | C-type lectin domain family 6, member A | | | | | |
| | Tissue enhanced | 0 |
CLEC7A | C-type lectin domain family 7, member A | | | | |
|
| | Tissue enhanced | 0 |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | | | | |
|
| | Tissue enhanced | 0 |
CRLF2 | Cytokine receptor-like factor 2 | | | | | |
| | Tissue enhanced | 0 |
CSF3 | Colony stimulating factor 3 (granulocyte) | | | | |
|
| | Tissue enhanced | 0 |
CTD-3088G3.8 | Protein LOC388210 | | | | |
|
| | Tissue enhanced | 0 |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | | | | | |
| | Tissue enhanced | 0 |
CXCL10 | Chemokine (C-X-C motif) ligand 10 | | | | | |
| | Tissue enhanced | 0 |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | | | | |
|
| | Tissue enhanced | 0 |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | | | | |
|
| | Tissue enhanced | 0 |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | | | | |
|
| | Tissue enhanced | 0 |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | | | | | |
| | Tissue enhanced | 0 |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | | | | |
|
| | Tissue enhanced | 0 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | | | | | |
| | Tissue enhanced | 0 |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) | | | | | |
| | Tissue enhanced | 0 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | | | | | |
| | Tissue enhanced | 0 |
FFAR2 | Free fatty acid receptor 2 | | | | |
|
| | Tissue enhanced | 0 |
FFAR3 | Free fatty acid receptor 3 | | | | |
|
| | Tissue enhanced | 0 |
FOXP3 | Forkhead box P3 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
FPR1 | Formyl peptide receptor 1 | | | | |
|
| | Tissue enhanced | 0 |
FPR2 | Formyl peptide receptor 2 | | | | |
|
| | Tissue enhanced | 0 |
FYB | FYN binding protein | | | | |
|
| Plasma membrane | Tissue enhanced | 0 |
GAL | Galanin/GMAP prepropeptide | | | | |
|
| Golgi apparatus Vesicles | Tissue enhanced | 0 |
GAPT | GRB2-binding adaptor protein, transmembrane | | | | |
|
| | Tissue enhanced | 0 |
GBP5 | Guanylate binding protein 5 | | | | |
|
| Endoplasmic reticulum | Tissue enhanced | 0 |
GPR84 | G protein-coupled receptor 84 | | | | |
|
| | Tissue enhanced | 0 |
HCK | Hemopoietic cell kinase | | | | |
|
| | Tissue enhanced | 0 |
IL11 | Interleukin 11 | | | | | |
| | Tissue enhanced | 0 |
IL4I1 | Interleukin 4 induced 1 | | | | |
|
| | Tissue enhanced | 0 |
IL7R | Interleukin 7 receptor | | | | |
|
| Plasma membrane | Tissue enhanced | 0 |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
JAK3 | Janus kinase 3 | | | | | |
| | Tissue enhanced | 0 |
LILRA1 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | | | | | |
| | Tissue enhanced | 0 |
LILRA3 | Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | | | | | |
| | Tissue enhanced | 0 |
LILRA5 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | | | | | |
| | Tissue enhanced | 0 |
LILRA6 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | | | | | |
| | Tissue enhanced | 0 |
LILRB1 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | | | | | |
| | Tissue enhanced | 0 |